Comparison

p-Synephrine vs Yohimbine

β3 agonist vs α2 blocker: Peripheral thermogenesis meets stubborn-fat mobilization.

Effectiveness Profile

p-Synephrine
Yohimbine

At a Glance

 p-SynephrineYohimbine
TypeSupplementSupplement
Legal statusOTCOTC
Half-life2–3 hours0.5–2.5 hours (mean ~36 min)
Preferred routeOralOral
Dose frequencytwice-dailyonce-daily
Beginner dose10–20 mg2.5–5 mg
Intermediate dose25–50 mg10–15 mg
Advanced dose50–75 mg15–25 mg
Cycle length4–8 wks4–12 wks
Bioavailability80%33%
Time to peak1.25h0.75h
Active duration4h2h
StorageRoom temperature, dry, away from lightRoom temperature, dry, away from light
PCT requiredNoNo
Ancillaries requiredNoNo
Safe for womenYesYes

Verdict

p-Synephrine wins for minimal CNS side effects, cardiovascular safety, broad tolerance at moderate doses, and convenience for extended-duration use. It is the preferred peripheral thermogenic when stacking with caffeine for general-cutting phases, especially in those seeking to avoid anxiety, jitters, or blood pressure spikes.

Yohimbine wins for targeted stubborn-fat mobilization, published efficacy in already-lean subjects, and acute potency during fasted cardio. It remains unmatched for α2-adrenergic blockade when the goal is to shed the last few percent of contest-prep or aesthetics-phase body fat — but carries higher risk for increased heart rate, blood pressure variability, and pronounced anxiety in sensitive subjects.

Pick A or B?

Pick p-Synephrine if:

  • The protocol calls for a thermogenic with minimal central stimulation or anxiety.
  • Stacking with caffeine in a general cutting stack over multiple weeks.
  • Moderate body-fat levels remain (not in single digits) and the goal is sustainable fat loss.
  • Sourcing, compliance, and routine use are priorities over acute potency.
  • Managing cardiovascular or anxiety risk is a key concern.

Pick Yohimbine if:

  • The objective is mobilizing stubborn fat (lower ab, hip, thigh) during the final phase of a cut.
  • The subject is already lean (men <12% BF, women <20% BF) and has plateaued.
  • Fasted cardio is scheduled and insulin levels will be kept low.
  • Speed and visible effect over a short timeframe (4–8 weeks) are the priority.
  • Subjects tolerate CNS stimulation and keep a close watch on cardiovascular responses.

Where to Buy

Swiss Chems

Swiss Chems

Ships from US

Affiliate link — we may earn a commission at no cost to you.

Use code-10%
BioMogging